Open Access

Triglyceride-rich lipoproteins in secondary prevention: do we need to treat?

Congress Session

About the speaker

Professor John Chapman

Sorbonne University, Paris (France)
15 presentations
0 follower

3 more presentations in this session

Lp(a): Is there any benefit from reducing it?

Speaker: Professor B. Ference (Cambridge, GB)

Thumbnail

Is it time to sing the requiem for HDL cholesterol?

Speaker: Professor U. Laufs (Leipzig, DE)

Thumbnail

Does LDL induce inflammation? If so, does it matter?

Speaker: Professor J. Jukema (Leiden, NL)

Thumbnail

Access the full session

Lipid-lowering therapy beyond LDL Cholesterol

Speakers: Professor J. Chapman, Professor B. Ference, Professor U. Laufs, Professor J. Jukema
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Related content

Open Access

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - panel .

27 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

Open Access

Triglycerides: the underestimated player.

27 August 2021

This platform is supported by

logo Novo Nordisk